Facetten
Zugriff
Einrichtung
Medientyp
- Text 12
Karte
Erscheinungsjahr
Autor/in
- Gambacorti-Passerini, Carlo
- Kantarjian, Hagop M 9
- Cortes, Jorge E 8
- Kim, Dong-Wook 8
- Brümmendorf, Tim H 7
- alle zeigen
Sprache
- Englisch 12
12 Einträge gefunden
-
Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study
- Gambacorti-Passerini, Carlo
- Cortes, Jorge E
- Lipton, Jeff H
- Kantarjian, Hagop M
- Kim, Dong-Wook
- Schafhausen, Philippe
- Crescenzo, Rocco
-
-
Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib
- Brümmendorf, Tim H
- Cortes, Jorge E
- Khoury, Hanna J
- Kantarjian, Hagop M
- Kim, Dong-Wook
- Schafhausen, Philippe
- Conlan, Maureen G
-
-
Long-term efficacy and safety of bosutinib in patients with advanced leukemia following resistance/intolerance to imatinib and other tyrosine kinase inhibitors
- Gambacorti-Passerini, Carlo
- Kantarjian, Hagop M
- Kim, Dong-Wook
- Khoury, Hanna J
- Turkina, Anna G
- Brümmendorf, Tim H
- Matczak, Ewa
-
Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukaemia:results from the 24-month follow-up of the BELA trial
- Brümmendorf, Tim H
- Cortes, Jorge E
- de Souza, Cármino Antonio
- Guilhot, Francois
- Duvillié, Ladan
- Pavlov, Dmitri
- Gogat, Karïn
-
Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24-month follow-up
- Gambacorti-Passerini, Carlo
- Brümmendorf, Tim H
- Kim, Dong-Wook
- Turkina, Anna G
- Masszi, Tamas
- Assouline, Sarit
- Durrant, Simon
-
-
A needle in a haystack: Identifying biomarkers to personalize systemic therapy in patients with hepatocellular carcinoma
2013 - Forschungsinformationssystem des UKE -
-
-
Inhibitors of the RET tyrosine kinase based on a 2-(alkylsulfanyl)-4-(3-thienyl)nicotinonitrile scaffold
2010 - Forschungsinformationssystem der UHH